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Effect of CsA on the expression of refill and angiotensin type 1 receptor
genes in the rat kidney. To determine whether Cyclosponne A (CsA)
alters the intrarenal expression of the renin and type 1 angiotensin II
receptor genes, male adult Sprague-Dawley rats were given 25 mg/kg!
day CsA s.c. for three weeks (CsA, N = 20) and were compared to
pair-fed vehicle treated rats (Con, N = 20). The intrarenal distribution
of renin and its mRNA was assessed by immunocytochemistry and in
situ hybridization. In addition, kidney renin and type 1 angiotensin II
(AT1) receptor mRNA levels were determined by Northern blot analy-
sis. The percentage of juxtaglomerular apparatuses containing renin
was higher in the CsA (84 5.5%) than in the Con (61 6.7%)group,(P < 0.05). The length of renin immunostaining along afferent arterioles
was higher in the CsA (74 4.5 m) than in the Con (37 5.1 m)
group, (P < 0.05). In contrast, neither renin mRNA levels nor its
intrarenal distribution were altered by chronic CsA administration.
Kidney AT1 receptor mRNA levels were lower in the CsA group than
in the Con group. We conclude that chronic CsA: (1) induces recruit-
ment of renin containing cells along the afferent arteriole, (2) causes no
changes in intrarenal renin mRNA levels or distribution, suggesting that
post-transcriptional events may be responsible for the persistence
and/or uptake of renin by the preglomerular vasculature, (3) promotes a
downregulation of AT1 receptor gene in the kidney, suggesting that
local angiotensin II may control AT1 receptor gene expression by a
negative feedback.
Treatment with Cyclosporine (CsA) is frequently compli-
cated by systemic and renal vasoconstriction [1—3], leading to
hypertension and renal dysfunction [3, 4]. In addition, CsA
alters the morphology [3, 5—7] and contractile response of the
renal microvasculature [8—9]. Although numerous abnormalities
have been described [10, 13], including increased activity of the
renal sympathetic nervous system [11, 14], altered renal ei-
cosanoid production favoring vasoconstriction [121, and en-
hanced endothelin activity [15, 16], the precise mechanisms
contributing to the development of chronic CsA-mediated Va-
soconstriction have not been identified [17].
There are also functional and morphologic data suggesting
that the renin-angiotensin system (RAS) may be involved in the
aforementioned alterations. Elevation in plasma renin activity
(PRA) and renal renin concentration and hyperplasia of the
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juxtaglomerular apparatus have been observed in animals
treated with CsA [18—20]. In addition, renin release from
cortical slices and isolated juxtaglomerular cells is enhanced by
CsA [21, 22]. Micropuncture studies demonstrate that CsA-
induced reductions in whole kidney and single nephron filtra-
tion and blood flow rates are associated with a decreased net
filtration pressure, together with an altered ratio of afferent and
efferent arteriolar resistances [9, 23, 24], suggesting an alter-
ation of local angiotensin II activity.
Whereas the available evidence suggests that CsA affects the
intrarenal RAS, it is unknown whether CsA alters the intrarenal
distribution of renin and/or its mRNA. Furthermore, it is
unknown whether CsA affects the expression of angiotensin II
receptors. Therefore, the present study was designed to deter-
mine whether chronic CsA administration alters the intrarenal
expression of the renin and type 1 angiotensin receptor (AT1)
genes. The intrarenal distribution of renin and renin mRNA was
determined using immunocytochemistry and in situ hybridiza-
tion histochemistry, respectively. Additionally, kidney renin
and AT1 mRNA levels were assessed by Northern and dot blot
analysis.
Methods
Male Sprague-Dawley rats (Taconic Farms) weighing 135 to
150 g were injected daily (s.c.) for 21 days with 25 mg/kg/day
CsA oral solution diluted with olive oil (CsA, N = 20) or an
equivalent amount of vehicle (Con, N = 20). Food consumption
was restricted in the Con animals to the average amount
consumed by the CsA treated rats. This simplified pair-feeding
protocol resulted in similar body weights in CsA (265 8.4 g)
and Con (263 7.1 g) groups at the time of experimentation.
Animals were anesthetized with mactin (100 mg/kg, i.p.). The
right femoral artery was catheterized with a P-SO polyethylene
tube for blood pressure measurement and blood sampling. PRA
was determined by radioimmunoassay [25] in 10 animals from
each group. Renal renin concentration (RRC) was determined
by radioimmunoassay [25] in homogenates of left kidneys of 10
rats in each group. Angiotensin I (Al) generated after incuba-
tion of renal homogenates for 30 minutes at pH 6.5 was
expressed as nanogram Al hour per kidney and nanogram
A! . hour mg protein'.
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Fig. 1. Immunolocalization of renin, Kidney tissue section from CsA treated rat showing a glomerulus with its afferent arteriole. Renin
immunoreactivity is observed in the JGA and along the afferent arteriole. Magnification x 500.
Renin immunocytochemistry
Kidneys from five animals in each group were perfused with
0.9% saline (20 ml) and 10% buffered formaldehyde (40 ml),
removed, decapsulated and processed for immunocytochemis-
try as previously described [26]. Kidneys were paraffin embedded
and serial sagittal sections (5 to 7 sm) were cut. Immunocyto-
chemical detection of renin was performed with the avidin-
biotin immunoperoxidase method [27]. The primary antibody
was a specific polyclonal anti-rat renin antibody raised in
rabbits (gift of Dr T, Inagami, Vanderbilt University), diluted
1:2500 [28]. The secondary antibody was a biotin-conjugated
anti-rabbit IgG raised in goats. Kidney sections were incubated
with avidin-horseradish peroxidase complex (Vectastain ABC
kits, Vector Laboratory, Burlingame, California, USA), ex-
posed to 0.1% diaminobenzidine tetrahydrochloride and 0.02%
}1202 as a source of peroxidase substrate and counterstained
with hematoxylin. Negative controls as indicated by absence of
staining included: (1) omission of the primary antibody, (2)
replacement of secondary antibody with non-immune rabbit
serum, and (3) omission of secondary antibody.
Three sections per animal were immunostained and examined
with light microscopy. The total number of juxtaglomerular
apparatuses (JGA) and those positively stained were counted in
each section. The total visible length of afferent arterioles (AA)
and the length positively stained were measured with an ocular
micrometer. Since the number of glomeruli, JGA and AA varied
from section to section, immunoreactive ream was expressed as
percent of JGA (%JGA) and percent of AA (%LAA) positively
stained [32]. The ratios obtained from each slide were pooled
and averaged for each animal.
Renin messenger RIJA levels and localization
Kidney levels and intrarenal distribution of renin mRNA
were determined by Northern blot analysis and in situ hybrid-
ization histochemistry, respectively. Total RNA was extracted
from the right kidneys of ten rats in each group according to the
method of Chirgwin eta! [29]. The RNA was dissolved in sterile
water and stored at —80°C until use. RNA concentration was
measured by spectrophotometry at 260 nm. Total RNA was
resolved by electrophoresis on 1.2% agarose-formaldehyde gels
and transferred to nylon membranes (Zetabind, Cuno mc,
Meriden, Connecticut, USA) by capillary action. In addition,
dot blots were prepared with kidney total RNA from CsA (N =
10) and Con (N = 10) rats. Northern and blots were hybridized
by the method of Church and Gilbert [301 with a full-length rat
kidney renin cDNA (gift of K. Lynch, University of Virginia)
labeled with 32P by nick translation [31] (sp. activity 1.83 x 10'
cpm4g) or by random priming [34] (sp. activity 2.3 x io
cpm/Lg). Hybridization signals were detected by autoradiogra-
phy and quantified by scanning densitometry (LKB 2222-020
Ultra Scan XL Laser densitometer, Bromma, Sweden).
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Fig. 2. Immunolocalization of renin. Kidney tissue section from a Con rat showing a glomerulus with its afferent arteriole. Renin immunoreactivity
is limited to the juxtaglomerular portion of the afferent arteriole. Magnification x 500.
In situ hybridization histochemistry
Five rats from each group were anesthetized with pentobar-
bital sodium (3 mg/100 g body wt i.p.) and kidneys were
prepared for in situ hybridization histochemistry, as previously
described with few modifications [26, 32]. Briefly, kidneys were
perfused with 4% paraformaldehyde in 0.12 M sodium phos-
phate, postfixed for one hour in the same solution and stored
overnight at 4°C in cryoprotection solution (30% sucrose in 0.12
Msodiumphosphate). Frozen sagittal sections (14 jsm) were cut
and mounted on positively charged slides. Sections were pre-
hybridized for one hour at 37°C and hybridized for 24 hours at
37°C to an oligonucleotide complementary to nucleotides 313 to
340 of rat renin mRNA [32]. The oligonucleotide was labeled at
the 3' end with -thio-35S-dATP to a specific activity of 1.46 x
iO counts min pmol '. After hybridization, the sections
were washed in decreasing concentrations of SSPE (lx SSPE
in 150 ifiM NaC1, 10 ifiM Na2HPO4 and 1 mM EDTA, pH 7.4)
containing 14 mai 2-mercaptoethanol and 1% sodium thiosul-
fate, followed by a high stringency wash at 51°C for 30 minutes
in 0.1 x SSPE. Then, sections were dehydrated, submitted to
emulsion autoradiography and stained with hematoxylin. Neg-
ative controls as indicated by absence of hybridization signals
were: (1) omission of the probe, and (2) hybridization with
sense 35S-labeled oligonucleotide. All slides from Con and CsA
treated animals were processed simultaneously.
In situ hybridization signals were counted by computer
digitization (Gould 1P8500, Biomedical Engineering, University
of Virginia) in three sections per animal. The number of JGA
with hybridization signals and the total number of JGA were
counted and calculations were made as described for immuno-
cytochemistry. In addition, the number of silver grains over
each JGA was computed for each section and an average was
obtained for each animal. However, since the number of grains
varied among sections and animals within a group, frequency
distribution polygons were used to further assess the grain
population in the CsA and Con groups.
Renal AT1 receptor ,nessenger RNA level
Kidneys from five CsA and five Con rats were pooled and
total RNA resolved by agarose gel electrophoresis as described
above. Dot blots were prepared with kidney total RNA from
individual CsA (N = 5) and Con (N = 5) rats. Northern and dot
blots were hybridized by Church and Gilbert's method [30] with
a 1133 base pair fragment of rat AT1 receptor cDNA (a gift of K.
Lynch, University of Virginia) [33] labeled with 32PdCTP to a
specific activity of 2.7 x l0 cpmIpg by random priming [34].
AT1 cDNA was obtained as follows: two oligonucleotides
(5'-GAT TTC GAA TAG TGT CTG AGA CC-3' and 5'-TTG
AAC CTG TCA CTC CAC CTC AA-3') were synthesized on a
BioSearch model 8600 synthesizer and purified by HPLC.
GsA Con
I.
Con
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was made by t-test for unpaired data. The difference between
frequency distribution polygons was tested by chi-square anal-
A ysis. Results are expressed as means SEM. Statistical signif-
icance was defined as P < 0.05.
B
Results
Mean arterial pressure was higher in CsA (118 5.3 mm Hg)
than in Con rats (102 1.8 mm Hg; P < 0.05). Plasma renin
activity was higher in CsA (7.9 1.37 ng AJJmlIhr) than in Con
rats (4.1 0.59 ng AI/ml/hr; P < 0.05). Renin content in whole
kidney homogenate was higher in CsA (4.6 0.36 x iO ng
AI/hr/g kidney) than in Con (3.64 0.24 x 1O ng AIIhr/g
C kidney; P < 0.05). These data indicate that three weeks of CsA
administration to rats was associated with the development of
hypertension and stimulation of the local renin-angiotensin
system.
Renin immunocytochemistry
0
Fig. 3. A. Representative Northern blot from Con and CsA rats.
Kidney total RNA (10 g) was loaded into each lane and hybridized
with 32P-labeled full length rat renin cDNA. CsA treatment did not alter
renin gene expression in the kidney. B. UV shadowing of Northern blot
shown in A. showing that RNA was evenly loaded. C. Representative
dot blot from CsA (N = 10) and Con (N = 10) rats. Total RNA (2 tg)
was immobilized and was hybridized to 32P-labeled full length rat renin
cDNA. D. Bar graph illustrating the densitometric analysis of autora-
diogram in C. The area below the absorbance curve is expressed in
arbitrary units as mean sE. < 0.05.
These oligonucleotides were used to amplify, by the poly-
merase chain reaction (PCR), a 1133 base pair fragment (nude-
otides #-44-1089) of cDNA encoding the rat AT1 receptor [33].
The conditions for the PCR were 94°C for one minute, 55°C for
two minutes, and 72°C for three minutes repeated for 25 cycles.
The DNA was amplified from approximately 1 ng of cDNA
synthesized from rat liver poly ARNA (Amersham cDNA
synthesis kit). The specific fragment was purified from an
agarose gel by electrophoresis onto DEAE-cellulose [35] and
either used as the hybridization probe directly or subcloned into
the Smal site of pOEM 7(z)f(+). Hybridization signals were
detected by autoradiography and quantitated by scanning den-
sitometry (LBK 2222-020 Ultrascan XL Laser densitometer,
Bromma, Sweden).
Statistical analysis
Comparison between blood pressure, plasma renin activity,
histochemical ratios and grain counts of CsA and Con groups
D The distribution of renin within the kidney of Con and CsA
treated rats is shown in Figures 1 and 2. Renin immunoreactiv-
ity was markedly enhanced in CsA (Fig. 1) when compared to
Con (Fig. 2). The intrarenal distribution of renin was altered in
the CsA group (Fig. 1). Immunoreactive renin was observed
along afferent arterioles upstream from the glomerulus in the
CsA group whereas it was limited to the classical juxtaglomer-
ular location in the Con group. The mean length of AA
immunostaining was higher in CsA (74.1 4.47 m) than in the
Con group (37 5.12 pm; P < 0.05). Also, the %LAA was
higher in CsA (64 5.4%) than in Con (25 1.3%), (P < 0.05).
Moreover, the %JGA was higher in CsA (84 5.5%) than in
Con (61 6.7%; P < 0.05).
Intrarenal renin mRNA levels and distribution
Figure 3 shows representative autoradiograms of Northern
and dot blots demonstrating that renin mRNA levels were not
altered in the CsA group. Quantification by optical densitome-
try measurements demonstrated the similarity between the two
groups.
The intrarenal distribution of renin mRNA was not signifi-
cantly altered in the CsA group. Hybridization signals were
limited to the kidney cortex and localized in the juxtaglomerular
apparatuses and the adjacent portion of afferent arterioles in
both groups of rats (Figs. 4 and 5). No extension of hybridiza-
tion signals along afferent arterioles was observed. The %JGA
containing hybridization signals was similar in the CsA (50
7.1%) and in the Con group (41 4.1%). The intensity of
hybridization signals, a function of the mRNA content per JGA,
was similar in CsA (274 51 grains/JGA) and in Con (293 38
grains/JGA). Figure 6 depicts the distribution of grains per JGA
in CsA and Con groups. The curves plotted are superposed and
no significant difference between the two groups was detected
by chi-square analysis.
Renal AT1 receptor mRNA
The decrease of kidney AT1 mRNA induced by chronic CsA
treatment is shown in Figure 7. The autoradiograms demon-
strate that renal steady state AT1 mRNA level is significantly
lower in CsA than in Con rats.
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Fig. 4. In situ hybridization for renjn mRNA. Kidney section from a CsA rat showing a glomerulus with its afferent arteriole. Hybridization signals
(silver grains) are localized to the JGA and distal portion of the afferent arteriole. Magnification X 500.
Discussion
The present study demonstrates that chronic CsA treatment
in rats: (1) increases circulating and renal renin, (2) alters the
intrarenal distribution of renin, (3) does not modify renin
mRNA levels nor its intrarenal distribution, and (4) downregu-
lates AT1 receptor gene expression.
Our findings of elevated mean arterial pressure, plasma renin
activity and renal renin content indicate that RAS activity is
enhanced both locally and systemically in CsA-treated rats.
These results are in agreement with previous reports showing
elevations of plasma renin activity and renal renin concentra-
tion in rats treated with varying doses of CsA for shorter
periods of time [10, 13, 181. Quantitative differences in renal
renin content between the present study and previous reports
are likely to be due to the fact that renin content was measured
in whole kidney homogenates in the present study. Alterna-
tively, renin storage may have been affected differently by the
various doses, species of experimental animal, duration of
treatment and routes of administration of CsA [10].
The immunocytochemical data of the present study demon-
strate that CsA alters the intrarenal distribution of renin.
CsA-induced enhancement of intrarenal vascular renin may
account for the aforementioned increase in renal renin content.
Our specific immunocytochemical staining confirms and ex-
tends previous light microscopy observations of JGA hyperpla-
sia and increased granule-containing cells along afferent arteri-
oles in CsA-treated animals [5, 201. Taken together, these data
suggest that CsA may induce increased renin synthesis. How-
ever, Northern blot analysis and in situ hybridization histo-
chemistry demonstrate that neither renin mRNA content nor its
distribution are altered after three weeks of CsA administration.
The discrepancy between the intrarenal distribution of renin
mRNA and its protein can be explained by several mechanisms
operating singly or in combination. First, CsA may induce
vascular uptake of renin. Previous studies have shown that the
vasculature is capable of taking up circulating renin [36].
Endothelial damage induced by CsA [6, 7] may have facilitated
diffusion of renin into the arterial wall. Second, CsA may
decrease protein turnover and cause it to accumulate within the
vessel wall. Different isoforms of renin have diverse metabolic
clearance rates and functions [40]. During chronic stimulation
of the RAS, acidic isoforms of renin having the longest half-life
have been shown to increase [40]. It remains to be determined
whether different renin isoforms are present in and/or released
from the renal vasculature of CsA-treated rats. Third, renin
gene expression may have varied during the time course of CsA
treatment. Fourth and less likely, CsA may decrease renin
mRNA half-life and therefore renin mRNA accumulation [37].
Further studies are necessary to elucidate the mechanism(s)
regulating renin synthesis and metabolism in response to CsA.
The present study demonstrates that AT1 receptor gene
expression is downregulated in the kidney following chronic
Fig. 5. In situ hybridization for renin mRNA. Kidney section from a Con rat showing a glomerulus (G) with its afferent arteriole (AA).
Hybridization signals are limited to the JGA. Magnification X 500.
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Fig. 6. Relative frequency distribution
polygons for the number of grains per JGA
(hybridization signals) in CsA (I, N 5) and
Con (0. N = 5) rats. Distribution polygons
from CsA and Con are similar (Chi-square,
1000 1200 NS). Inset: mean number of grains per JGA is
similar in CsA and Con rats (unpaired t-test,
NS).
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CsA treatment in the rat. It is possible that high local levels of gering the molecular alterations described in the present study
Ang II modulate AT1 gene expression. This hypothesis, how- remain to be determined. CsA raises sympathetic nervous
ever, remains to be tested. The physiologic mechanisms trig- system activity in humans and animals [11, 19] and stimulates
CsA
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Fig. 7. A. Northern Blot: Pooled total RNA (10 jig) from CsA (lane 1,
N =5) and Con (lane 2, N =5) rat kidneys were loaded and hybridized
to a 32P-labeled 1.1 kb rat AT1 cDNA. AT1 mRNA levels are decreased
(3 fold) in CsA treated rats. B. UV shadowing of Northern blot in A
showing even loading of RNA. C. Dot blot: total RNA from CsA (N =
5) and Con (N = 5) rat kidney was blotted and hybridized as in A. AT1
mRNA levels are decreased twofold in CsA treated rats. D. Bar graph
illustrating the densitometric analysis of autoradiogram shown in C.
The area below the absorbance curve is expressed in arbitrary units as
mean sa. *P < 0.05.
endothelial factors that may modulate the vascular RAS, that is,
eicosanoids and endothelin [41]. Although sympathetic stimu-
lation may account for the enhanced activity of intrarenal RAS
[42], it has been shown that renal denervation only partially
reverses the renal vasoconstriction following acute and chronic
CsA-treatment [9, 14]. Therefore, other stimuli, including mac-
ula densa activation and/or the renal baroreceptor mechanism
are likely to be involved in the local activation of RAS in this
model. Renal hypoperfusion, acutely determined by enhanced
endothelin [15, 16] and/or thromboxane [12] activities, is the
most likely initial trigger for intrarenal RAS activation.
Although acute experimental CsA-induced renal vasocon-
striction is blocked by angiotensin converting enzyme inhibition
[44], numerous studies have shown that acute blockade of the
intrarenal RAS only partially reverses more chronic CsA vaso-
constriction [8, 9, 231. Indeed, chronic angiotensin converting
enzyme inhibition with enalapril during CsA administration
worsened CsA-induced JGA hyperplasia and the resultant
tubulointerstitial disease [45]. Therefore, there may be signifi-
cant functional differences in the activation and regulation of
the intrarenal RAS that are dependent on the length of exposure
to varying doses of CsA.
The alterations in renin and AT1 gene expression described in
CsA treated rats may be responsible, at least in part, for some
of the CsA-induced changes in renal vascular reactivity and
autoregulation previously observed in this model [8, 23]. In
addition, downregulation of AT1 receptors may provide the
molecular basis for the blunted vascular response to acute
infusions of Ang II in vitro [43] and for the "relative All
insufficiency" state described in CsA treated rats [9]. Down-
regulation of AT1 mRNA may also represent an adaptive
mechanism attempting to attenuate both glomerular and sys-
temic hypertension.
Extrapolation of our results in a relatively short-term model
of CsA treatment to chronic CsA nephropathy seen in humans
after prolonged administration is tenuous. Nevertheless, CsA-
associated arteriolopathy occurs in afferent arterioles of hu-
mans where hyperplasia of the JGA has been reported [10].
Thus, it is possible that early activation of the intrarenal RAS
by CsA may be one of the numerous important events in the
subsequent development of the more chronic renovascular
changes that often occur with long-term CsA treatment.
In summary, the present investigation demonstrates that
short-term chronic CsA administration in the rat is character-
ized by intrarenal expression of renin and AT1 receptor genes.
First, CsA resulted in recruitment of renin containing cells
along afferent arterioles. Second, intrarenal renin mRNA levels
and distribution were not altered by chronic CsA treatment,
suggesting that renin content may be controlled by post-tran-
scriptional events. Finally, CsA-induced downregulation of
AT1 receptor gene expression in the kidney may contribute to
the altered vascular reactivity of the renal vasculature in
CsA-treated rats.
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